• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Front Immunol . Unraveling the impact of SARS-CoV-2 mutations on immunity: insights from innate immune recognition to antibody and T cell responses

tetano

Editor, Senior Moderator
Front Immunol


. 2024 Dec 10:15:1412873.
doi: 10.3389/fimmu.2024.1412873. eCollection 2024. Unraveling the impact of SARS-CoV-2 mutations on immunity: insights from innate immune recognition to antibody and T cell responses

Rafael Bayarri-Olmos[SUP] 1 2 [/SUP], Adrian Sutta[SUP] #[/SUP][SUP] 1 2 [/SUP], Anne Rosbjerg[SUP] 1 2 [/SUP], Mie Mandal Mortensen[SUP] 3 [/SUP], Charlotte Helgstrand[SUP] 3 [/SUP], Per Franklin Nielsen[SUP] 3 [/SUP], Laura Pérez-Alós[SUP] 1 [/SUP], Beatriz González-García[SUP] 1 [/SUP], Laust Bruun Johnsen[SUP] 3 [/SUP], Finn Matthiesen[SUP] 3 [/SUP], Thomas Egebjerg[SUP] 3 [/SUP], Cecilie Bo Hansen[SUP] 1 [/SUP], Alessandro Sette[SUP] 4 5 [/SUP], Alba Grifoni[SUP] 4 [/SUP], Ricardo da Silva Antunes[SUP] 4 [/SUP], Peter Garred[SUP] 1 6 [/SUP]



Affiliations
Abstract

Throughout the COVID-19 pandemic, the emergence of new viral variants has challenged public health efforts, often evading antibody responses generated by infections and vaccinations. This immune escape has led to waves of breakthrough infections, raising questions about the efficacy and durability of immune protection. Here we focus on the impact of SARS-CoV-2 Delta and Omicron spike mutations on ACE-2 receptor binding, protein stability, and immune response evasion. Delta and Omicron variants had 3-5 times higher binding affinities to ACE-2 than the ancestral strain (KD[SUB]wt[/SUB] = 23.4 nM, KD[SUB]Delta[/SUB] = 8.08 nM, KD[SUB]BA.1[/SUB] = 4.77 nM, KD[SUB]BA.2[/SUB] = 4.47 nM). The pattern recognition molecule mannose-binding lectin (MBL) has been shown to recognize the spike protein. Here we found that MBL binding remained largely unchanged across the variants, even after introducing mutations at single glycan sites. Although MBL binding decreased post-vaccination, it increased by 2.6-fold upon IgG depletion, suggesting a compensatory or redundant role in immune recognition. Notably, we identified two glycan sites (N717 and N801) as potentially essential for the structural integrity of the spike protein. We also evaluated the antibody and T cell responses. Neutralization by serum immunoglobulins was predominantly mediated by IgG rather than IgA and was markedly impaired against the Delta (5.8-fold decrease) and Omicron variants BA.1 (17.4-fold) and BA.2 (14.2-fold). T cell responses, initially conserved, waned rapidly within 3 months post-Omicron infection. Our data suggests that immune imprinting may have hindered antibody and T cell responses toward the variants. Overall, despite decreased antibody neutralization, MBL recognition and T cell responses were generally unaffected by the variants. These findings extend our understanding of the complex interplay between viral adaptation and immune response, underscoring the importance of considering MBL interactions, immune imprinting, and viral evolution dynamics in developing new vaccine and treatment strategies.

Keywords: MBL; SARS-CoV-2; delta; immune imprinting; mannose-binding lectin; omicron; vaccine; variants of concern.

 
Back
Top Bottom